Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2012
08/23/2012US20120214832 Isoform selective phospholipase d inhibitors
08/23/2012US20120214824 Proteostasis regulators
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214809 Aminoindane Compounds and Use Thereof in Treating Pain
08/23/2012US20120214807 Compounds useful as antagonists of ccr2
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214790 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
08/23/2012US20120214783 Viral polymerase inhibitors
08/23/2012US20120214769 Novel Antagonists of the Glucagon Receptor
08/23/2012US20120214768 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/23/2012US20120214253 Macrocyclic hopo chelators
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120211743 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME
08/23/2012CA2827282A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/23/2012CA2826648A1 Aminoindane compounds and use thereof in treating pain
08/23/2012CA2825737A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2489657A2 Inhibitors of histone deacetylase
08/22/2012EP2488532A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488521A1 Macrocyclic integrase inhibitors
08/22/2012EP2488520A1 Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor
08/22/2012EP2488519A1 Pyrazolopyridine derivatives as anticancer agent
08/22/2012EP2488518A2 Herbicidal compounds
08/22/2012EP2488514A1 Indole and azaindole modulators of the alpha 7 nachr
08/22/2012EP2488513A2 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
08/22/2012EP2488512A1 Cgrp receptor antagonists
08/22/2012EP2488500A1 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
08/22/2012EP2488492A2 Protected amine labels and use in detecting analytes
08/22/2012EP2488177A1 Filamin a binding anti-inflammatory and analgesic
08/22/2012EP2193118B1 Piperidine and piperazine derivatives for treating tumours
08/22/2012EP1976836B1 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
08/22/2012EP1963346B1 Organometallic complex and light-emitting element, light-emitting device and electronic device using the same
08/22/2012EP1940838B1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
08/22/2012EP1401829B1 Novel heterocyclic antibacterial compounds
08/22/2012CN1980791B Perylene n-type semiconductors and related devices
08/22/2012CN102648200A 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
08/22/2012CN102648195A Novel spiropiperidine compounds
08/22/2012CN102648193A Spirocyclic compounds as modulators of chemokine receptor activity
08/22/2012CN102643276A Immunosuppressive agent FR901483 intermediate and synthetic method thereof
08/22/2012CN102153552B Two novel paliperidone drug eutectics and preparation method of the novel paliperidone drug eutectics
08/22/2012CN101787022B Quinoline carboxylic acid hydrochloride-hydrate novel crystal form, and preparation method thereof
08/21/2012US8247556 Method for preparing 6-substituted-7-aza-indoles
08/21/2012US8247428 Indole alkaloid derivatives having opioid receptor agonistic effect, and therapeutic compositions and methods relating to same
08/21/2012US8247424 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
08/21/2012US8247408 Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
08/21/2012US8247401 P2X3 receptor antagonists for treatment of pain
08/21/2012CA2476828C 2-amino-4-bicyclylamino-6h-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/16/2012WO2012108490A1 Isoquinoline amide derivative
08/16/2012WO2012108376A1 Amino group-containing pyrrolidinone derivative
08/16/2012WO2012107549A1 PROCESS FOR OBTAINING COMPOUNDS DERIVED FROM TETRAHYDRO-ß-CARBOLINE
08/16/2012WO2012107465A1 Heterocyclic compounds as pi3 kinase inhibitors
08/16/2012WO2012106995A1 Rorgammat inhibitors
08/16/2012WO2012088124A3 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
08/16/2012WO2012082593A3 Electroactive 1,7- and 4,10- diazachrysene derivatives and devices made with such materials
08/16/2012WO2012061342A3 Substituted benzo-imidazo-pyrido-diazepine compounds
08/16/2012WO2011092469A8 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
08/16/2012WO2011042389A3 Phenylpyri(mi)dinylazoles and their use as fungicides
08/16/2012US20120209000 Chemical compounds
08/16/2012US20120208997 Novel compound having heterocyclic ring
08/16/2012US20120208989 Fluorinated aromatic materials and their use in optoelectronics
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208839 New compounds
08/16/2012US20120208837 Substituted azaindoles
08/16/2012US20120208829 2-phenoxy pyrimidinone analogues
08/16/2012US20120208828 Azole Derivatives as WTN Pathway Inhibitors
08/16/2012US20120208827 Benzimidazoles as fatty acid synthase inhibitors
08/16/2012US20120208820 Diazabicyclic central nervous system active agents
08/16/2012US20120208819 Heterocyclic compounds useful as pdk1 inhibitors
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208811 Aminopyrazole Derivative
08/16/2012US20120208809 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
08/16/2012US20120208796 Heterocyclic derivatives
08/16/2012US20120208794 Fused heterocyclic ring derivative and use thereof
08/16/2012US20120208791 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
08/16/2012US20120207769 Inhibitors of IAP
08/16/2012US20120207751 Imidazoquinolines as lipid kinase inhibitors
08/16/2012US20120205629 Semiconductor compound
08/16/2012US20120205605 Organic redox active compounds with reversible storage of charges and substrates and molecular memory devices comprising them
08/16/2012DE102012201973A1 Halbleiterverbindung Semiconductor compound
08/16/2012CA2828059A1 Rorgammat inhibitors
08/16/2012CA2825028A1 Heterocyclic compounds as pi3 kinase inhibitors
08/15/2012EP2487180A1 Novel artificial fluorescent bases
08/15/2012EP2487176A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/15/2012EP2487175A1 Pharmaceutical product containing aromatic heterocyclic compound
08/15/2012EP2487174A2 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
08/15/2012EP2487159A1 RorgammaT inhibitors
08/15/2012EP2486038A1 Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
08/15/2012EP2486037A2 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
08/15/2012EP2486036A2 Materials for organic electroluminescent devices
08/15/2012EP2486034A1 Spirocyclic compounds as modulators of chemokine receptor activity
08/15/2012EP2486031A2 Phenylpyri(mi)dinylpyrazoles and their use as fungicides
08/15/2012EP2486009A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
08/15/2012EP2485736A1 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP2485728A1 Wnt pathway antagonists
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 646